Recurrent Stenoses in Arteriovenous Fistula (AVF) for Dialysis Access: cuttIng ballooN angioplaSTy combined wITh paclitaxel drUg-coaTed balloon angioplasty, an observatIONal study (INSTITUTION Study).
Cutting balloon
Dialysis fistula
Drug coated balloon
Journal
Cardiovascular and interventional radiology
ISSN: 1432-086X
Titre abrégé: Cardiovasc Intervent Radiol
Pays: United States
ID NLM: 8003538
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
21
05
2021
accepted:
26
10
2021
pubmed:
22
1
2022
medline:
22
4
2022
entrez:
21
1
2022
Statut:
ppublish
Résumé
To study the safety and efficacy of cutting balloon angioplasty (CBA) followed by paclitaxel drug-coated balloon (PCB) angioplasty for recurrent venous lesions in arteriovenous fistulas (AVFs). We conducted a prospective single-arm cohort study of CBA followed by PCB angioplasty for recurrent AVF stenoses between September 2017 and April 2019. In total, 44 participants were recruited. Target lesions were included if they had recurred within 12 months post-angioplasty, were > = 0.5 cm upstream from the arteriovenous anastomosis, and did not involve the central veins. Up to two non-target lesions per circuit/participant with the same definition were allowed. Lesions were considered separate when there was an intervening 2-cm segment of normal vessel. Technical success was defined as complete lesion effacement on angioplasty. End-points of target and circuit patency were evaluated clinically at 3, 6, and 12 months post-procedure. Technical success was 96% (42/44): Two participants were excluded from analysis due to the need for high-pressure balloon angioplasty as the target lesions did not efface with CBA. The median follow-up duration was 337.5 days. Mean stenosis pre- and post-angioplasty was 69.0% (51.6-84.8) and 20.8% (0-44.8), respectively. The target lesion primary, primary assisted and circuit patency for the entire study population (n = 42) were 61.6 ± 7.8%, 92.7 ± 4.0%, and 54.7 ± 7.9%, respectively, at 12 months. For participants without non-target lesions (n = 22), the rates were 77.3 ± 8.9%, 90.9 ± 6.1%, and 60.7 ± 11.0%, respectively, at 12 months. CBA followed by PCB angioplasty appears safe and feasible for treatment of recurrent venous lesions in dysfunctional AVFs.
Identifiants
pubmed: 35059796
doi: 10.1007/s00270-021-03030-w
pii: 10.1007/s00270-021-03030-w
doi:
Substances chimiques
Coated Materials, Biocompatible
0
Paclitaxel
P88XT4IS4D
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
646-653Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2021. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
Références
Daugirdas JT, Depner TA, Inrig J, Mehrotra R, Rocco MV, Suri RS, Weiner DE, Greer N, Ishani A, MacDonald R, Olson C, Rutks I, Slinin Y, Wilt TJ, Rocco M, Kramer H, Choi MJ, Samaniego-Picota M, Scheel PJ, Willis K, Joseph J, Brereton L. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis. 2015;66(5):884–930.
doi: 10.1053/j.ajkd.2015.07.015
Glanz S, Gordon DH, Butt KM, Hong J, Lipkowitz GS. The role of percutaneous angioplasty in the management of chronic hemodialysis fistulas. Ann Surg. 1987;206(6):777–81.
doi: 10.1097/00000658-198712000-00015
Schwab SJ, Raymond JR, Saeed M, Newman GE, Dennis PA, Bollinger RR. Prevention of hemodialysis fistula thrombosis. Early Detect Venous Stenoses, Kidney Int. 1989;36(4):707–11.
P.P.G.M. Rooijens, J.H.M. Tordoir, T. Stijnen, J.P.J. Burgmans, A.A.E.A. Smet de, T.I. Yo, Radiocephalic wrist arteriovenous fistula for hemodialysis: meta-analysis indicates a high primary failure rate. Eur J Vasc Endovasc Surg, 28(6) (2004) 583–589.
Roy-Chaudhury P, Sukhatme VP, Cheung AK. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol. 2006;17(4):1112–27.
doi: 10.1681/ASN.2005050615
Chen B, Wang P, Brem A, Dworkin L, Liu Z, Gong R. Mineralocorticoid receptor: a hidden culprit for hemodialysis vascular access dysfunction. EBioMedicine. 2019;39:621–7.
doi: 10.1016/j.ebiom.2018.11.054
Chang C-J, Ko P-J, Hsu L-A, Ko Y-S, Ko Y-L, Chen C-F, Huang C-C, Hsu T-S, Lee Y-S, Pang J-HS. Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of restenosis. Am J Kidney Dis. 2004;43(1):74–84.
doi: 10.1053/j.ajkd.2003.09.015
Peregrin JH, Roček M. Results of a peripheral cutting balloon prospective multicenter European registry in hemodialysis vascular access. Cardiovasc Intervent Radiol. 2007;30(2):212–5.
doi: 10.1007/s00270-006-0020-0
Aftab SA, Tay KH, Irani FG, Gong Lo RH, Gogna A, Haaland B, Tan SG, Chng SP, Pasupathy S, Choong HL, Tan BS. Randomized clinical trial of cutting balloon angioplasty versus high-pressure balloon angioplasty in hemodialysis arteriovenous fistula stenoses resistant to conventional balloon angioplasty. J Vasc Interv Radiol. 2014;25(2):190–8.
doi: 10.1016/j.jvir.2013.10.020
Irani FG, Teo TKB, Tay KH, Yin WH, Win HH, Gogna A, Patel A, Too CW, Chan S, Lo RHG, Toh LHW, Chng SP, Choong HL, Tan BS. Hemodialysis arteriovenous fistula and graft stenoses: randomized trial comparing drug-eluting balloon angioplasty with conventional angioplasty. Radiology. 2018;289(1):238–47.
doi: 10.1148/radiol.2018170806
Lookstein RA, Haruguchi H, Ouriel K, Weinberg I, Lei L, Cihlar S, Holden A. Drug-coated balloons for dysfunctional dialysis arteriovenous fistulas. N Engl J Med. 2020;383(8):733–42.
doi: 10.1056/NEJMoa1914617
Trerotola SO, Saad TF, Roy-Chaudhury P. The lutonix av randomized trial of paclitaxel-coated balloons in arteriovenous fistula stenosis: 2-year results and subgroup analysis. J Vasc Interv Radiol. 2020;31(1):1-14.e5.
doi: 10.1016/j.jvir.2019.08.035
Rajabi-Jaghargh E, Banerjee RK. Combined functional and anatomical diagnostic endpoints for assessing arteriovenous fistula dysfunction. World J Nephrol. 2015;4(1):6–18.
doi: 10.5527/wjn.v4.i1.6
Quencer KB, Arici M. Arteriovenous fistulas and their characteristic sites of stenosis. Am J Roentgenol. 2015;205(4):726–34.
doi: 10.2214/AJR.15.14650
Jennings WC, Galt SW, Shenoy S, Wang S, Ladenheim ED, Glickman MH, Kathuria P, Browne BJ. The Venous Window Needle Guide, a hemodialysis cannulation device for salvage of uncannulatable arteriovenous fistulas. J Vasc Surg. 2014;60(4):1024–32.
doi: 10.1016/j.jvs.2014.04.016
Gray RJ, Sacks D, Martin LG, Trerotola SO. Reporting standards for percutaneous interventions in dialysis access. J Vasc Interv Radiol. 2003;14(9):S433–42.
doi: 10.1097/01.RVI.0000094618.61428.58
F.G. Irani, B.S. Tan, Drug coated balloons: are they the holy grail for dysfunctional dialysis arteriovenous fistulas?, CardioVascular and Interventional Radiology (2020).
Cejna M. Cutting balloon: review on principles and background of use in peripheral arteries. Cardiovasc Intervent Radiol. 2005;28(4):400–8.
doi: 10.1007/s00270-004-0115-4
Saleh HM, Gabr AK, Tawfik MM, Abouellail H. Prospective, randomized study of cutting balloon angioplasty versus conventional balloon angioplasty for the treatment of hemodialysis access stenoses. J Vasc Surg. 2014;60(3):735–40.
doi: 10.1016/j.jvs.2014.04.002
Rasuli P, Chennur VS, Connolly MJ, Hadziomerovic A, Pomerleau FE, Ryan SE, French GJ, O’Kelly K, Aina R, Champagne P, Petrcich W. Randomized trial comparing the primary patency following cutting versus high-pressure balloon angioplasty for treatment of de novo venous stenoses in hemodialysis arteriovenous fistulae. J Vasc Interv Radiol. 2015;26(12):1840-6.e1.
doi: 10.1016/j.jvir.2015.08.024
Vesely TM, Siegel JB. Use of the peripheral cutting balloon to treat hemodialysis-related stenoses. J Vasc Interv Radiol. 2005;16(12):1593–603.
doi: 10.1097/01.RVI.0000190928.19701.DD
Ierardi AM, Franchin M, Fontana F, Piffaretti G, Duka E, Tonolini M, Miele V, Tozzi M, Carrafiello G. Usefulness of paclitaxel-releasing high-pressure balloon associated with cutting balloon angioplasty for treatment of outflow stenoses of failing hemodialysis arteriovenous shunts. Radiol Med. 2017;122(1):69–76.
doi: 10.1007/s11547-016-0680-z
Zheng J, Cui J, Meiyan Qing J, Irani Z. Safety and effectiveness of combined scoring balloon and paclitaxel-coated balloon angioplasty for stenosis in the hemodialysis access circuit. Diagn Inter Imaging. 2019;100(1):31–7.
doi: 10.1016/j.diii.2018.05.014